Pregled bibliografske jedinice broj: 1041800
Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment
Functional ibuprofen-loaded cationic nanoemulsion: development and optimization for dry eye disease treatment // International journal of pharmaceutics, 576 (2020), 118979, 13 doi:10.1016/j.ijpharm.2019.118979 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1041800 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Functional ibuprofen-loaded cationic nanoemulsion:
development and optimization for dry eye disease
treatment
Autori
Jurišić Dukovski, Bisera ; Juretić, Marina ; Bračko, Danka ; Randjelović, Danijela ; Savić, Snežana ; Crespo Moral, Mario ; Diebold, Yolanda ; Filipović-Grčić, Jelena ; Pepić, Ivan ; Lovrić, Jasmina
Izvornik
International journal of pharmaceutics (0378-5173) 576
(2020);
118979, 13
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
dry eye disease ; nanoemulsion ; NSAID ; chitosan ; lecithin
Sažetak
Inflammation plays a key role in dry eye disease (DED) affecting millions of people worldwide. Non- steroidal anti-inflammatory drugs (NSAIDs) can be used topically to act on the inflammatory component of DED, but their limited aqueous solubility raises formulation issues. The aim of this study was development and optimization of functional cationic nanoemulsions (NEs) for DED treatment, as a formulation approach to circumvent solubility problems, prolong drug residence at the ocular surface and stabilize the tear film. Ibuprofen was employed as the model NSAID, chitosan as the cationic agent, and lecithin as the anionic surfactant enabling chitosan incorporation. Moreover, lecithin is a mixture of phospholipids including phosphatidylcholine and phosphatidylethanolamine, two constituents of the natural tear film important for its stability. NEs were characterized in terms of droplet size, polydispersity index, zeta-potential, pH, viscosity, osmolarity, surface tension, entrapment efficiency, stability, sterilizability and in vitro release. NEs mucoadhesive properties were tested rheologically after mixing with mucin dispersion. Biocompatibility was assessed employing 3D HCE- T cell-based model and ex vivo model using porcine corneas. The results of our study pointed out the NE formulation with 0.05% (w/w) chitosan as the lead formulation with physicochemical properties adequate for ophthalmic application, mucoadhesive character and excellent biocompatibility.
Izvorni jezik
Engleski
Znanstvena područja
Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb
Profili:
Ivan Pepić
(autor)
Bisera Jurišić
(autor)
Jelena Filipović-Grčić
(autor)
Jasmina Lovrić
(autor)
Marina Juretić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE